Expanding Phenotypic Spectrum of Cerebral Aspartate–Glutamate Carrier Isoform 1 (AGC1) Deficiency

Abstract

Case We are reporting the third unrelated case of cerebral aspartate–glutamate carrier isoform 1 (AGC1) deficiency. Patient is a 21-month-old Yemeni male who presented with refractory seizure disorder and developmental arrest. Neuroimaging showed cerebral volume loss and diminished N-acetylaspartate (NAA) peak. Whole exome sequencing revealed a homozygous novel missense variant in the SLC25A12 gene. Patient's seizure frequency abated drastically following initiation of ketogenic diet.

Discussion and Conclusion Cerebral AGC1 deficiency results in dysfunction of mitochondrial malate aspartate shuttle, thereby prohibiting myelin synthesis. There are significant phenotypic commonalities between our patient and previously reported cases including intractable epilepsy, psychomotor delay, cerebral atrophy, and diminished NAA peak. Our report also provides evidence regarding beneficial effect of ketogenic diet in this rare neurometabolic epilepsy.

Keywords

SLC25A12 - aspartate–glutamate carrier - whole exome sequencing - ketogenic diet

• References

• 1 Amoedo ND, Punzi G, Obre E. , et al. AGC1/2, the mitochondrial aspartate-glutamate carriers. Biochim Biophys Acta 2016; 1863 (10) 2394-2412
• 2 Contreras L. Role of AGC1/aralar in the metabolic synergies between neuron and glia. Neurochem Int 2015; 88: 38-46
• 3 Wibom R, Lasorsa FM, Töhönen V. , et al. AGC1 deficiency associated with global cerebral hypomyelination. N Engl J Med 2009; 361 (05) 489-495
• 4 Falk MJ, Li D, Gai X. , et al. AGC1 deficiency causes infantile epilepsy, abnormal myelination, and reduced N-acetylaspartate. JIMD Rep 2014; 14: 77-85
• 5 Pronicka E, Piekutowska-Abramczuk D, Ciara E. , et al. New perspective in diagnostics of mitochondrial disorders: two years' experience with whole-exome sequencing at a national paediatric centre. J Transl Med 2016; 14 (01) 174
• 6 Jalil MA, Begum L, Contreras L. , et al. Reduced N-acetylaspartate levels in mice lacking aralar, a brain- and muscle-type mitochondrial aspartate-glutamate carrier. J Biol Chem 2005; 280 (35) 31333-31339
• 7 Wolf NI, van der Knaap MS. AGC1 deficiency and cerebral hypomyelination. N Engl J Med 2009; 361 (20) 1997-1998 , author reply 1998
• 8 Ramos M, Pardo B, Llorente-Folch I, Saheki T, Del Arco A, Satrústegui J. Deficiency of the mitochondrial transporter of aspartate/glutamate aralar/AGC1 causes hypomyelination and neuronal defects unrelated to myelin deficits in mouse brain. J Neurosci Res 2011; 89 (12) 2008-2017
• 9 Kobayashi K, Saheki T. Aspartate glutamate carrier (citrin) deficiency. In: Broer S, Wagner CS. , eds. Membrane Transporter Diseases. New York, NY: Kluwer Academic/Plenum Publishers; 2003: 147-160
• 10 Dahlin M, Martin DA, Hedlund Z, Jonsson M, von Döbeln U, Wedell A. The ketogenic diet compensates for AGC1 deficiency and improves myelination. Epilepsia 2015; 56 (11) e176-e181